What does FSFF stand for?

Female Sexual Function Forum (women's health)

This definition appears very rarely and is found in the following Acronym Finder categories:

Organizations, NGOs, schools, universities, etc.

Other Resources:

<< Previous	Abbreviation Database Surfer		Next >>
Functional/Sub-Functional Category Feng Shui Fortune Chime Silver Fort Sill Federal Credit Union (Oklahoma) File System Filter Driver (data encryption/decryption) Financial Sector Foreign Direct Investment Flight Simulator French Development Team (gaming) Fiji Seventh Form Examination Free Software Foundation Europe Final Supplemental Final Environmental Impact Statement Fuzzy Stochastic Finite Element Method		Free Software Foundation France Fédération Sportive Féminine Internationale (French: International Federation of Women's Sports; est. 1911) Federazione fra le Società Filateliche Italiane (Italian: Federation of the Italian Philatelic Societies) Female Sexual Function Index Flight Safety Foundation International (Russia) Free Software Foundation of India Farm Storage Facility Loan (USDA) Fox Sports Florida Free-Standing Fixed Line Free Software Foundation Latin America

Samples in periodicals archive:

Product Pipeline Update Data from our first trial with ALISTA(TM), our proprietary topical formulation of alprostadil (prostaglandin E1) for Female Sexual Arousal Disorder (FSAD), was presented at the Female Sexual Function Forum in Boston in October of 2001.

VIVUS REPORTS NET LOSSES FOR 4TH QTR AND YEAR END 2001

Paper presented at Female Sexual Function Forum, Boston, MA.

A New View of Women's Sexual Problems: Why New? Why Now?

It presented intranasal apomorphine data for male and female sexual dysfunction at the Female Sexual Function Forum over the weekend in Boston.

OTHER NEWS TO NOTE

In October 2000, at the Female Sexual Function Forum, Nastech presented Phase I pharmacokinetic data on the administration of intranasal apomorphine in 12 healthy female subjects which indicated the formulation to be safe and well tolerated.

Nastech Begins Phase II Trial for Female Sexual Dysfunction

Nasdaq:VVUS) today announced that the Company will present data from its first clinical trial with ALISTA(TM), its proprietary topical formulation of alprostadil for the treatment of female sexual dysfunction (FSD), at the Female Sexual Function Forum in Boston, Massachusetts on Saturday, October 27, 2001 at 9:00 a.

VIVUS To Present At Female Sexual Function Forum in Boston, Mass. On ...

Company Presents Intranasal Apomorphine Clinical Data for Male and Female Sexual Dysfunction at Female Sexual Function Forum - HAUPPAUGE, N.

Nastech Initiates Phase II Intranasal Apomorphine Trial for Male ...

Data from the Company's first trial with ALISTA was accepted for presentation at the Female Sexual Function Forum in Boston and will be presented at 9 a.

VIVUS Reports Third Quarter Financial Results

Nastech presented intranasal apomorphine clinical data for male and female sexual dysfunction at the Female Sexual Function Forum in Boston this weekend.

Nastech Initiates Phase II Intranasal Apomorphine Trial for Male ...